In November 2016, IK Investment Partners, a European private equity firm, acquired ZytoService Group, a leading compounder of pharmaceuticals for patient-individualised infusions, from the founders and Capiton. ZytoService is, through the acquisition and greenfield opening of outpatient oncology practices, also the largest focused oncology practice group in the DACH region.
The parties have agreed not to disclose the financial terms of the transaction.
Abolon acted as exclusive commercial due diligence advisor to IK Investment Partners.
English 
Deutsch